Meds & supplements › Tetrabenazine
Medicine · Vesicular Monoamine Transporter 2 Inhibitor
Tetrabenazine tablets are indicated for the treatment of chorea associated with Huntington's disease.
Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗
WARNING: DEPRESSION AND SUICIDALITY Tetrabenazine can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington’s disease. Anyone considering the use of tetrabenazine must balance the risks of depression and suicidality with the clinical need for control of chorea. Close observation of patients for the emergence or worsening of depression, suicidality, or unusual changes in behavior should accompany therapy. Patients, their caregivers, and families should be informed of the risk of depression and suicidality and should be instructed to report behaviors of concern promptly to the treating physician. Particular caution should be exercised in treating patients with a history of depression or prior suicide attempts or ideation, which are increased in frequency in Huntington’s disease. Tetrabenazine is contraindicated in patients who are actively suicidal, and in patients with untreated or inadequately treated depression. WARNING: DEPRESSION AND SUICIDALITY See full prescribing information for complete boxed warning. Increases the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington’s disease Balance risks of depression and suicidality with the clinical need for control of chorea when considering the use of tetrabenazine tablets Monitor patients for the emergence or worsening of depression, suicidality, or unusual changes in behavior Inform patients, caregivers and families of the risk of depression and suicidality and instruct to report behaviors of concern promptly to the treating physician Exercise caution when treating patients with a history of depression or prior suicide attempts or ideation Tetrabenazine tablets are contraindicated in patients who are actively suicidal, and in patients with untreated or inadequately treated depression
Tetrabenazine tablets are a medicine that is used to treat the involuntary movements (chorea) of Huntington's disease. Tetrabenazine tablets do not cure the cause of the involuntary movements, and it does not treat other symptoms of Huntington's disease, such as problems with thinking or emotions.
It is not known whether tetrabenazine tablets are safe and effective in children.
Call the doctor right away if you become depressed or have any of the following symptoms, especially if they are new, worse, or worry you:
Tetrabenazine tablets can cause serious side effects, including:
Common side effects with tetrabenazine tablets include:
Tell your doctor if you have any side effects. Do not stop taking tetrabenazine tablets without talking to your doctor first.
Call your doctor for medical advice about side effects. You may report side effects to the Food and Drug Administration (FDA) at 1–800–FDA-1088.
General information about tetrabenazine tablets
Tetrabenazine tablets contain the active ingredient tetrabenazine. It also contains these inactive ingredients: anhydrous lactose, colloidal silicon dioxide, croscarmellose sodium and magnesium stearate. The 25 mg tablet, which is yellow, also contains ferric oxide yellow.
Store at 20°C to 25°C (68°F to 77°F).
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use tetrabenazine tablets for a condition for which it was not prescribed. Do not give tetrabenazine tablets to other people, even if they have the same symptoms that you have. It may harm them. Keep tetrabenazine tablets out of the reach of children.
This Medication Guide summarizes the most important information about tetrabenazine tablets. If you would like more information, talk with your doctor. You can ask your doctor or pharmacist for information about tetrabenazine tablets that is written for healthcare professionals. You can also call Apotex at 1-800-706-5575.
This Medication Guide has been approved by the U.S. Food and Drug Administration.
All registered trademarks in this document are the property of their respective owners.
APOTEX INC. Tetrabenazine Tablets 12.5 mg, 25 mg
Revised: November 2021
Revision: 5
Do not take tetrabenazine tablets if you:
Tell your doctor about all your medical conditions, including if you:
Tell your doctor about all the medicines you take, including prescription medicines and nonprescription medicines, vitamins and herbal products. Using tetrabenazine tablets with certain other medicines may cause serious side effects. Do not start any new medicines while taking tetrabenazine tablets without talking to your doctor first.
Sleepiness (sedation) is a common side effect of tetrabenazine tablets. While taking tetrabenazine tablets, do not drive a car or operate dangerous machinery until you know how tetrabenazine affects you. Drinking alcohol and taking other drugs that may also cause sleepiness while you are taking tetrabenazine tablets may increase any sleepiness caused by tetrabenazine tablets.
sofidex [Internet]. Daloreum; c2026. Tetrabenazine; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/tetrabenazine
sofidex. (2026, August 2). Tetrabenazine. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/tetrabenazine
Tetrabenazine. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/tetrabenazine
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.